NICE granted wider role as local government advisors

NICE will adopt an even larger role in health policy after being given the go-ahead to advise local authorities on which public health schemes are value for money.

The new role, first reported by GP in July, will see NICE advise local directors of public health on which schemes are value for money and effective. The institute will use similar methods employed to assess the value of new drugs.

It signals the latest step in an expanding role for the institute, which covers health, social and now local government policy.

NICE was handed the role after a 'return-on-investment' study that it was commissioned by the DH to perform found that many public health interventions are effective and good value for money.

Professor Mike Kelly, NICE's director of the Centre for Public Health Excellence, said the 'briefings' it will produce would provide 'tailored practical advice' to help authorities, who are to take over responsibility for public health under the NHS reforms.

He added: 'The briefings will distil the recommendations from existing NICE public health and clinical guidance on a range of essential topics such as tackling tobacco and obesity, increasing physical activity, and topics on alcohol and health, and workplace health.'

The advice will help raise awareness of those public health activities and approaches which are proven to be effective, and how they can not only improve the health of local people, but also often save money, he said.

The NICE paper found many public health interventions were 'excellent' value for money.

Co-author Professor Kelly said: 'Given the current economic climate it’s more important than ever to make best use of limited resources.'

The paper found that 85% of public health interventions were cost-effective at a threshold of £20,000 per quality-adjusted life year.

This figure is far less than the maximum threshold usually used by NICE for assessing drug treatments of around £30,000.

Health professionals are invited, along with the public and other stakeholders, to apply for a position on a new committee to guide the development of the briefings.

The first briefings are expected in April 2012.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Girl receiving vaccine

GPs raise 'substantial concerns' over workload impact of polio boosters

London GP leaders have raised 'substantial concerns' that practices do not have the...

GP consultation

Patient satisfaction with GPs varies more than two-fold between PCNs

Overall patient satisfaction with general practice varies more than two-fold between...

Dr Lucy McKay, CEO Medics4RareDiseases

Viewpoint: GPs can support patients with rare diseases without being expert in their condition

Around 1 in 17 people in the UK are affected by a rare disease. Dr Lucy McKay explains...

Polio vaccine

GP practices likely to spearhead polio booster campaign for all children in London aged 1-9

All children aged between one and nine in Greater London are to be offered a polio...

Medicines on shelf in a pharmacy

Medicine shortages increased in past year piling workload pressure on GPs

Medicine shortages have become worse during the past year, leading to increased GP...

The team at Minehead Medical Centre

Somerset GP practice converts to John Lewis-style employee-ownership model

A GP practice in Somerset has become the first in England to operate as a John Lewis-style...